Agrawal S, Umapathy S, Dhiman RK (2015) Minimal hepatic encephalopathy impairs quality of life. J Clin Exp Hepatol 5(Suppl 1):S42–S48. https://doi.org/10.1016/j.jceh.2014.11.006

Article  PubMed  Google Scholar 

Agustí A, Cauli O, Rodrigo R, Llansola M, Hernández-Rabaza V, Felipo V (2011) p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Gut 60(11):1572–1579. https://doi.org/10.1136/gut.2010.236083

Article  CAS  PubMed  Google Scholar 

Agustí A, Hernández-Rabaza V, Balzano T, Taoro-Gonzalez L, Ibañez-Grau A, Cabrera-Pastor A, Fustero S, Llansola M, Montoliu C, Felipo V (2017) Sildenafil reduces neuroinflammation in cerebellum, restores GABAergic tone, and improves motor in-coordination in rats with hepatic encephalopathy. CNS Neurosci Ther 23(5):386–394. https://doi.org/10.1111/cns.12688

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arenas YM, Balzano T, Ivaylova G, Llansola M, Felipo V (2022) The S1PR2-CCL2-BDNF-TrkB pathway mediates neuroinflammation and motor incoordination in hyperammonaemia. Neuropathol Appl Neurobiol 48(4):e12799. https://doi.org/10.1111/nan.12799

Article  CAS  PubMed  Google Scholar 

Arenas YM, Izquierdo-Altarejos P, Martinez-García M, Giménez-Garzó C, Mincheva G, Doverskog M, Jones DEJ, Balzano T, Llansola M, Felipo V (2024) Golexanolone improves fatigue, motor incoordination and gait and memory in rats with bile duct ligation. Liver Int 44(2):433–445. https://doi.org/10.1111/liv.15782

Article  CAS  PubMed  Google Scholar 

Bajaj JS, Heuman DM, Sanyal AJ, Hylemon PB, Sterling RK, Stravitz RT, Fuchs M, Ridlon JM, Daita K, Monteith P, Noble NA, White MB, Fisher A, Sikaroodi M, Rangwala H, Gillevet PM (2013) Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 8(4):e60042. https://doi.org/10.1371/journal.pone.0060042

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balzano T, Forteza J, Molina P, Giner J, Monzó A, Sancho-Jiménez J, Urios A, Montoliu C, Felipo V (2018a) The cerebellum of patients with steatohepatitis shows lymphocyte infiltration, microglial activation and loss of purkinje and granular neurons. Sci Rep 14;8(1):3004. https://doi.org/10.1038/s41598-018-21399-6

Balzano T, Forteza J, Borreda I, Molina P, Giner J, Leone P, Urios A, Montoliu C, Felipo V (2018b) Histological features of cerebellar neuropathology in patients with alcoholic and Nonalcoholic Steatohepatitis. J Neuropathol Exp Neurol 77(9):837–845. https://doi.org/10.1093/jnen/nly061

Article  CAS  PubMed  Google Scholar 

Balzano T, Dadsetan S, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Malaguarnera M, Gil-Perotin S, Cubas-Nuñez L, Casanova B, Castro-Quintas A, Ponce-Mora A, Arenas YM, Leone P, Erceg S, Llansola M, Felipo V (2020) Chronic hyperammonemia induces peripheral inflammation that leads to cognitive impairment in rats: reversed by anti-TNF-α treatment. J Hepatol 73(3):582–592. https://doi.org/10.1016/j.jhep.2019.01.008

Article  CAS  PubMed  Google Scholar 

Balzano T, Leone P, Ivaylova G, Castro MC, Reyes L, Ramón C, Malaguarnera M, Llansola M, Felipo V (2021) Rifaximin prevents T-Lymphocytes and macrophages infiltration in cerebellum and restores motor incoordination in rats with mild liver damage. Biomedicines 2;9(8):1002. https://doi.org/10.3390/biomedicines9081002

Balzano T, Llansola M, Arenas YM, Izquierdo-Altarejos P, Felipo V (2023) Hepatic encephalopathy: investigational drugs in preclinical and early phase development. Expert Opin Investig Drugs 32(11):1055–1069. https://doi.org/10.1080/13543784.2023.2277386

Article  CAS  PubMed  Google Scholar 

Cabrera-Pastor A, Llansola M, Montoliu C, Malaguarnera M, Balzano T, Taoro-Gonzalez L, García-García R, Mangas-Losada A, Izquierdo-Altarejos P, Arenas YM, Leone P, Felipo V (2019) Peripheral inflammation induces neuroinflammation that alters neurotransmission and cognitive and motor function in hepatic encephalopathy: underlying mechanisms and therapeutic implications. Acta Physiol (Oxf) 226(2):e13270. https://doi.org/10.1111/apha.13270

Article  CAS  PubMed  Google Scholar 

Cauli O, Rodrigo R, Piedrafita B, Boix J, Felipo V (2007) Inflammation and hepatic encephalopathy: ibuprofen restores learning ability in rats with portacaval shunts. Hepatology 46(2):514–519. https://doi.org/10.1002/hep.21734

Article  CAS  PubMed  Google Scholar 

Cauli O, Rodrigo R, Piedrafita B, Llansola M, Mansouri MT, Felipo V (2009) Neuroinflammation contributes to hypokinesia in rats with hepatic encephalopathy: ibuprofen restores its motor activity. J Neurosci Res 87(6):1369–1374. https://doi.org/10.1002/jnr.21947

Article  CAS  PubMed  Google Scholar 

Cheng J, Shah YM, Ma X, Pang X, Tanaka T, Kodama T, Krausz KW, Gonzalez FJ (2010) Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther 335(1):32–41. https://doi.org/10.1124/jpet.110.170225

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadsetan S, Balzano T, Forteza J, Agusti A, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Gomez-Gimenez B, ElMlili N, Llansola M, Felipo V (2016a) Infliximab reduces peripheral inflammation, neuroinflammation, and extracellular GABA in the cerebellum and improves learning and motor coordination in rats with hepatic encephalopathy. J Neuroinflammation 13(1):245. https://doi.org/10.1186/s12974-016-0710-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, Gil-Perotín S, Cubas-Núñez L, García-Verdugo JM, Agusti A, Llansola M, Felipo V (2016b) Reducing Peripheral inflammation with Infliximab reduces Neuroinflammation and improves cognition in rats with hepatic Encephalopathy. Front Mol Neurosci 9:106. https://doi.org/10.3389/fnmol.2016.00106

Article  CAS  PubMed  PubMed Central  Google Scholar 

Elfferich MD, Nelemans PJ, Ponds RW, De Vries J, Wijnen PA, Drent M (2010) Everyday cognitive failure in sarcoidosis: the prevalence and the effect of anti-TNF-alpha treatment. Respiration 80(3):212–219. https://doi.org/10.1159/000314225

Article  CAS  PubMed  Google Scholar 

Erceg S, Monfort P, Hernández-Viadel M, Rodrigo R, Montoliu C, Felipo V (2005) Oral administration of sildenafil restores learning ability in rats with hyperammonemia and with portacaval shunts. Hepatology 41(2):299–306. https://doi.org/10.1002/hep.20565

Article  CAS  PubMed  Google Scholar 

Eskilsson A, Mirrasekhian E, Dufour S, Schwaninger M, Engblom D, Blomqvist A (2014) Immune-induced fever is mediated by IL-6 receptors on brain endothelial cells coupled to STAT3-dependent induction of brain endothelial prostaglandin synthesis. J Neurosci 6;34(48):15957-61. https://doi.org/10.1523/JNEUROSCI.3520-14.2014

Esposito G, Nobile N, Gigli S, Seguella L, Pesce M, d’Alessandro A, Bruzzese E, Capoccia E, Steardo L, Cuomo R, Sarnelli G (2016) Rifaximin improves clostridium difficile toxin a-induced toxicity in caco-2 cells by the PXR-Dependent TLR4/MyD88/NF-κB pathway. Front Pharmacol 7:120. https://doi.org/10.3389/fphar.2016.00120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Felipo V (2013) Hepatic encephalopathy: effects of liver failure on brain function. Nat Rev Neurosci 14(12):851–858. https://doi.org/10.1038/nrn3587

Article  CAS  PubMed  Google Scholar 

Felipo V, Ordoño JF, Urios A, El Mlili N, Giménez-Garzó C, Aguado C, González-Lopez O, Giner-Duran R, Serra MA, Wassel A, Rodrigo JM, Salazar J, Montoliu C (2012a) Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance in attention tests. Hepatology 55(2):530–539. https://doi.org/10.1002/hep.24704

Article  PubMed  Google Scholar 

Felipo V, Urios A, Montesinos E, Molina I, Garcia-Torres ML, Civera M, Olmo JA, Ortega J, Martinez-Valls J, Serra MA, Cassinello N, Wassel A, Jordá E, Montoliu C (2012b) Contribution of hyperammonemia and inflammatory factors to cognitive impairment in minimal hepatic encephalopathy. Metab Brain Dis 27(1):51–58. https://doi.org/10.1007/s11011-011-9269-3

Article  CAS  PubMed  Google Scholar 

Felipo V, Urios A, Valero P, Sánchez M, Serra MA, Pareja I, Rodríguez F, Gimenez-Garzó C, Sanmartín J, Montoliu C (2013) Serum nitrotyrosine and psychometric tests as indicators of impaired fitness to drive in cirrhotic patients with minimal hepatic encephalopathy. Liver Int 33(10):1478–1489. https://doi.org/10.1111/liv.12206

Article  CAS  PubMed  Google Scholar 

Fiorillo A, Gallego JJ, Casanova-Ferrer F, Giménez-Garzó C, Urios A, Ballester MP, Durbán L, Rios MP, Megías J, San Miguel T, Kosenko E, Escudero-García D, Benlloch S, Felipo V, Montoliu C (2023) Mild cognitive impairment is Associated with enhanced activation of Th17 lymphocytes in non-alcoholic fatty liver disease. Int J Mol Sci 24(12):10407. https://doi.org/10.3390/ijms241210407

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giménez-Garzó C, Garcés JJ, Urios A, Mangas-Losada A, García-García R, González-López O, Giner-Durán R, Escudero-García D, Serra MA, Soria E, Felipo V, Montoliu C (2017) The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients. PLoS ONE 12(2):e0171211. https://doi.org/10.1371/journal.pone.0171211

Article